Imidafenacin, a potent and selective antagonist of the M1 and M3-muscarinic receptor subtypes, is safe, efficacious, and tolerable for controlling the symptoms of overactive bladder (OAB). However, the precise mechanisms responsible for the bladder-selective pharmacological effects of this agent remain unclear.